Published March, 2022
By Reginald Kelly
Publisher: Elsevier (States Academic Press)
Rating:
Availability: Available

---

Published March, 2022
By Seiji Isonishi and Yoshihiro Kikuchi
Publisher: Springer (Springer Verlag, Singapore)
Rating:
Availability: Available

---

Published March, 2022
By Bertil E. Damato
Publisher: Springer (Springer Nature Switzerland AG)
Rating:
Availability: Available

---

Published March, 2022
By Hillary W. Garner
Publisher: Elsevier (Elsevier - Health Sciences Division)
Rating:
Availability: Available

---

Published March, 2022
By Alessandro Lagana
Publisher: Springer (Springer Nature Switzerland AG)
Rating:
Availability: Available

Precision medicine holds great promise for the treatment of cancer and represents a unique opportunity for accelerated development and application of novel and repurposed therapeutic approaches.

---

Published March, 2022
By Khalid Raza
Publisher: Springer (Springer Verlag, Singapore)
Rating:
Availability: Available

This book encapsulates recent applications of CI methods in the field of computational oncology, especially cancer diagnosis, prognosis, and its optimized therapeutics. The cancer has been known as a heterogeneous disease categorized in several different subtypes.

---

Published March, 2022
By Nancy Hunt
Publisher: Elsevier (States Academic Press)
Rating:
Availability: Available

---

Published March, 2022
By Canaan Burton
Publisher: Elsevier (States Academic Press)
Rating:
Availability: Available

---

Published March, 2022
By Frankie Harvey
Publisher: Elsevier (States Academic Press)
Rating:
Availability: Available

---

Published February, 2022
By Bir Bahadur, Chukwuebuka Egbuna, K. Saravanan, Horne Iona Averal, S. Kannan and S. Elavarasi
Publisher: Elsevier (Apple Academic Press Inc.)
Rating:
Availability: Available

Drug Development for Cancer and Diabetes: A Path to 2030 focuses on new developments in the discovery of drugs for the treatment of cancer and diabetes. This new book presents important recent advances, emerging trends, and novel innovations for these two world-leading diseases.

---